Stephan Hjorth
-
Does In Vitro Potency Predict Clinically Efficacious
Concentrations?
R. Jansson-Lofmark, Stephan Hjorth, J. Gabrielsson
Clinical Pharmacology and Therapeutics - 2020-01-01 -
Reoperations After Bariatric Surgery in 26 Years of Follow-up of the Swedish Obese Subjects
Study.
Stephan Hjorth, Ingmar Näslund, Johanna C. Andersson-Assarsson, Per-Arne Svensson, Peter Jacobson, Markku Peltonen, Lena M S Carlsson
JAMA surgery - 2019-01-01 -
Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese
subjects.
Lena M S Carlsson, Kajsa Sjöholm, Sofie Ahlin, Peter Jacobson, Johanna C. Andersson-Assarsson, Linda Karlsson-Lindahl, Cristina Maglio, Cecilia Karlsson, Stephan Hjorth, Magdalena Taube, Björn Carlsson, Per-Arne Svensson, Markku Peltonen
International journal of obesity (2005) - 2019-01-01 -
Dose-Response-Time Data Analysis: An Underexploited
Trinity
J. Gabrielsson, R. Andersson, M. Jirstrand, Stephan Hjorth
Pharmacological reviews - 2019-01-01 -
Lost in translation: What's in an EC50? Innovative PK/PD reasoning in the drug development
context
J. Gabrielsson, L. A. Peletier, Stephan Hjorth
European Journal of Pharmacology - 2018-01-01 -
In vivo potency revisited - Keep the target in
sight
J. Gabrielsson, L. A. Peletier, Stephan Hjorth
Pharmacology & Therapeutics - 2018-01-01 -
Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects
study.
Lena M S Carlsson, Kajsa Sjöholm, Cecilia Karlsson, Peter Jacobson, Johanna C. Andersson-Assarsson, Per-Arne Svensson, Ingrid Larsson, Stephan Hjorth, Martin Neovius, Magdalena Taube, Björn Carlsson, Markku Peltonen
The lancet. Diabetes & endocrinology - 2017-01-01 -
Discovery of New Drugs for Weight Loss and Prevention of Weight
Regain
Anders Lehmann, Udo Bauer, Stephan Hjorth, Rudolph Leibel, Michael Rosenbaum
Neuroendocrinology of Appetite. S Dickson & J Mercer (eds.) - 2016-01-01 -
Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain
Sensation
Mikael Bjursell, E. Ryberg, T. T. Wu, P. J. Greasley, M. Bohlooly-Y, Stephan Hjorth
Plos One - 2016-01-01 -
Looking back (and in)to the future: A personal reflection on 'Serotonin autoreceptor function and antidepressant drug action' (Hjorth et
al.2000)
Stephan Hjorth
Journal of Psychopharmacology - 2016-01-01 -
Pattern Recognition in Pharmacodynamic Data
Analysis
Johan Gabrielsson, Stephan Hjorth
AAPS Journal - 2016-01-01 -
Modeling energy intake by adding homeostatic feedback and drug
intervention
Peter Gennemark, Stephan Hjorth, J. Gabrielsson
Journal of Pharmacokinetics and Pharmacodynamics - 2015-01-01 -
Osteoporosis in MCHR1-deficient
mice.
Mohammad Bohlooly-Yeganeh, Margit Mahlapuu, Harriet Andersén, Annika Astrand, Stephan Hjorth, Lennart Svensson, Jan Törnell, Michael R Snaith, David G Morgan, Claes Ohlsson
Biochemical and biophysical research communications - 2004-01-01 -
Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in
vivo.
H. Jörgen Bengtsson, Julianna Kele, Johan Johansson, Stephan Hjorth
Naunyn-Schmiedeberg's archives of pharmacology - 2000-01-01